1 The Impending Crisis in CNS Drug Development.
2 Animal Models and Procedures for CNS Disorders.
3 Pre-Clinical Antecedents to Early Human Clinical Trials.
4 Biomarkers and Surrogate Markers in Drug Development.
5 Neuroimaging and Cognitive Assessments in Early Drug Development.
6 Bridging and CSF Studies.
7 A Case Study from Pre-Clinical to Early Clinical Trials.
Review copy sent(x2) 25/05/11: Doody Enterprises, Inc.